A carregar...
US-based Drug Cost Parameter Estimation for Economic Evaluations
INTRODUCTION: In the US, more than 10% of national health expenditures are for prescription drugs. Assessing drug costs in US economic evaluation studies is not consistent, as the true acquisition cost of a drug is not known by decision modelers. Current US practice focuses on identifying one reason...
Na minha lista:
Publicado no: | Med Decis Making |
---|---|
Main Authors: | , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
2014
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4472562/ https://ncbi.nlm.nih.gov/pubmed/25532826 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0272989X14563987 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|